Page 275 - Cardiac Nursing
P. 275

M
                                     1 P
                                          Pa
                                        M
                                     1 P
                                   1
                                   1
                                   0:2
                                   0:2
                                              51
                                            e 2
                                                A
                                              51
                                            e 2
                                           g
                                          Pa
                                           g
                                           g
                                /09
                          q
                      5-2
                           xd
                           xd
                      5-2
                          q
                          q
                        66.
                        66.
                              /29
                             6
                                /09
                              /29
                             6
                    24
                    24
                              6
                   p
                                                A
         LWBK340-c11_ p pp245-266.qxd  6/29/09  10:21 PM  Page 251 Aptara Inc.
                 11_
                 11_
                                                    In
                                                      c.
                                                      c.
            K34
         LWB
         LWB
               0-c
               0-c
            K34
                                                    In
                                                  t
                                                 p
                                                 p
                                                  t
                                                  ara
                                                  ara
                                                  ara
                                                   a
                                                   a
                                                   a
                                                 p
                                                   a
                                                                        C HAPTER 11 / Laboratory Tests Using Blood  251
                   evaluate the clinical signs and symptoms and other diagnostic  depends on laboratory analysis of CK isoenzymes and may well
                   tests to ensure accurate diagnosis and treatment.   be imperative in critically ill patients with multiple organ system
                                                                       involvement.
                   Cardiac Enzymes                                       Because of the wide range in baseline values among “healthy”
                                                                       people, and various enzyme assay techniques, there are no uni-
                   Enzymes are protein substances that catalyze chemical reactions in  form reference values for CK and CK isoenzymes. Consequently,
                   cells but do not themselves enter into the reaction. Substrates in the  the practice of reporting the isoenzyme as a percentage of the to-
                   cells bind to the enzymes and form products. After the reaction, the  tal CK, as well as in U/L has been encouraged.
                   enzyme molecule is free to undergo the same reaction with other
                   substrate molecules. Specific enzymes are responsible for nearly  Creatine Kinase-BB.  The brain fraction CK-BB (CK-1) is
                   every chemical reaction in the body. Some enzymes are present in  seen infrequently in serum. Its rare appearance has been associated
                   almost all cells; others are specific to cells of certain organs.  with brain trauma, cerebral contusions, and cerebrovascular acci-
                                                                       dents. The presence of CK-BB in association with cancer has been
                   Creatine Kinase                                     reported. Other causes of serum CK-BB activity include malignant
                   Creatine kinase is an enzyme specific to cells of the brain, my-  hyperthermia, renal failure, and after central nervous system sur-
                                                                          3
                   ocardium, and skeletal muscle, but also is found in minimal  gery. With the significant improvement in diagnostic imaging
                   amounts in other tissues, such as smooth muscle. In these organ  techniques, CK-BB is now rarely evaluated.
                   systems, the function of CK is primarily that of energy produc-  Creatine Kinase-MM.  CK-MM constitutes almost the en-
                   tion, where it serves as a catalyst in the phosphorylation of adeno-  tire CK total in healthy people. Skeletal muscle injury or severe
                   sine diphosphate (ADP) to creatine and adenosine triphosphate  muscle exertion is the most frequent source of high serum CK-
                   (ATP). In this manner, CK is responsible for the transfer of an  MM (CK-3) levels. Specific examples include myopathy, vigorous
                   energy-rich bond to ADP. This reaction provides a rapid means of  exercise, multiple intramuscular (IM) injections, electroconvulsive
                   forming ATP for contractile activity in muscle as well as for en-  therapy, cardioversion, surgery, muscular dystrophy, convulsions,
                   ergy requirements in nonmuscle tissue. The reaction is reversible,  and delirium tremens. Elevations in CK-MM fractions have also
                   and ATP can phosphorylate creatine to form creatine phosphate  been noted in conditions producing less obvious effects on muscle,
                   and ADP during periods of rest.                     such as hypokalemia and hypothyroidism. 3
                     In an acute MI, inadequate oxygen delivery to the myocardium
                   causes cell injury. An acidic environment promotes the activity of  Creatine Kinase-MB.  Prior to the discovery of troponin,
                   lysosomal enzymes, which are responsible for cell membrane dam-  CK-MB (CK-2) isoenzyme analysis had been an accepted means
                   age or destruction. CK is among the cellular enzymes that diffuse  for diagnosis of an acute MI. Although troponin has superseded
                   from the damaged cell into the blood. CK is released after irre-  CK-MB in the diagnosis of MI, most institutions continue to eval-
                   versible injury. The appearance of CK in the blood indicates  uate CK, CK-MB, and troponin if MI is suspected.
                   cardiac, cerebral, or skeletal muscle necrosis or injury and follows  When CK-MB is released from myocardial tissue, it has a bio-
                   a predictable rise and fall over a specified time (see Fig. 11-1).  logic half-life in blood of hours-to-days. Total CK and CK-MB
                     Age, sex, race, physical activity, lean body mass, medications,  rise within 2 to 8 hours after an acute MI. Peak levels are seen
                   and other unidentified factors are known to affect total CK. A pa-  within 18 to 36 hours and are more than six times their normal
                   tient’s baseline CK level is related to his or her overall muscle  value. If no additional myocyte necrosis occurs, levels return to
                   mass. Adults have lower values than children. Serum CK declines  normal within 3 to 4 days. See Table 11-2 and Figure 11-1 for the
                   with age and older adults have very low values. CK values meas-  typical appearance, peak, and disappearance of various biomark-
                   ured in women are lower than those of men; European Americans  ers and enzymes.
                   have lower values than African Americans. Chronic exercise raises  Elevated CK-MB levels have also been reported after myocar-
                   serum CK levels; however, there is a training effect, and well-  dial damage from unstable angina, cardiac surgery, coronary an-
                   trained athletes have smaller increases in CK after physical exer-  gioplasty, after defibrillation, in vigorous exercise, and after IM in-
                   tion. Medications that may increase CK include anticoagulants,  jections, trauma, and surgery. Early and abnormally high increases
                   aspirin, furosemide, captopril, lidocaine, propranolol, and mor-  in CK are sometimes seen after reperfusion by PCI or throm-
                   phine. In addition, high-intensity lipid-lowering therapy with  bolytic agents. By 6 to 8 hours postangioplasty, 20% of patients
                   lipophilic statins (i.e., simvastatin or lovastatin) have been found  have a mild increase in CK-MB. Elevations are occasionally seen
                   to increase CK. 33  Early and abnormally high increases in CK are  in pericarditis, myocarditis, viral myositis, and sustained tach-
                   sometimes seen after reperfusion by PCI (Chapter 23) or throm-  yarrhythmias. An increase in CK-MB may occur after cardiover-
                   bolytic agents. 2,3                                 sion, but that time course for increase is different for that of MI,
                     The importance of monitoring the concentration of serum  with the mild increase of CK-MB peaking within 4 hours of car-
                   CK is related to its specificity in the organ in which it functions.  dioversion.
                   Slightly different molecular forms (isoenzymes or isozymes) of CK  Specimens for CK and CK-MB are collected on admission and
                   have different tissues of origin. The three CK isoenzymes are  8 to 12 hours later. CK and CK isoenzyme results should be eval-
                   combinations of the protein subunits, named for their primary  uated along with troponin, myoglobin, ECG results, and clinical
                   sites of isolation—the muscle (M) and brain (B). CK-MM is the  signs and symptoms for the detection of MI. Laboratory slips
                   predominant muscle isoenzyme, found in cardiac and skeletal  should be marked with the date and time of any IM injections
                   muscle. It also can  be  detected in normal serum.  The my-  given to the patient in the prior 24 to 48 hours.
                   ocardium is primarily responsible for the CK-MB form. CK-BB  Caution should be exercised in interpretation of CKs drawn in
                   is present in the brain, lung, stomach, prostate, and smooth mus-  the emergency department. Only 25% to 40% of patients who are
                   cle of the gastrointestinal tract and bladder. Diagnostic precision  having an MI have an abnormal CK at that point. An initial
   270   271   272   273   274   275   276   277   278   279   280